Mind Medicine Inc (NAS:MNMD)
$ 8.19 -0.78 (-8.7%) Market Cap: 600.59 Mil Enterprise Value: 438.17 Mil PE Ratio: 0 PB Ratio: 2.93 GF Score: 41/100

Q2 2022 Mind Medicine (MindMed) Inc Earnings Call Transcript

Aug 11, 2022 / 08:30PM GMT
Release Date Price: $9.75 (-0.21%)
Operator

Good afternoon, and welcome to the Mind Medicine second-quarter 2022 financial results and corporate update conference call. (Operator Instructions) As a reminder, this conference call is being recorded.

It is now my pleasure to introduce your host, Robert Barrow, Chief Executive Officer and Director at Mind Medicine. Mr. Barrow, you may begin your conference.

Robert Barrow;MindMed;Inc.;CEO;Board Director
Mind Medicine

()-&

Thank you, operator, and good afternoon, everyone. Welcome to MindMed second-quarter 2022 financial results and corporate update conference call.

Following market close today, we issued a press release with the summary of our results. The press release reporting our financial results is available in the Investors and Media section of MindMed's website. And our quarterly report on Form 10-Q for the quarter ended June 30, 2022, will be filed today with the Securities and Exchange Commission.

Joining me on today's call is Schond Greenway, our Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot